Marianne Benn

Marianne Benn is a Clinical Professor in the Department of Clinical Medicine, specializing in Clinical Biochemistry at the University of Copenhagen's Faculty of Health and Medical Sciences. She works with the Research and Innovation Office and is based at Blegdamsvej 3B, 2200 København N.

Dr. Benn holds qualifications as a Medical Doctor, PhD, and DMSc. Her academic credentials reflect a strong foundation in both clinical medicine and advanced scientific research.

Marianne Benn's research focuses on genetic epidemiology in translational medicine, specifically using Mendelian randomization in large population cohorts including the Copenhagen General Population Study, the Copenhagen City Heart Study, and the UK Biobank. Her work aims to differentiate biomarkers with causal effects on disease from simple markers of disease, identify patterns of common genetic variants defining individuals at high risk of disease, predict effects of drugs from genetic variation in genes targeted by the drugs, and use genetics to predict public health effects of treatment or intervention. Her research spans cardiovascular disease, metabolic disorders, and the genetic basis of various health conditions with significant clinical implications.

Her publication record demonstrates expertise across cardiology, genetic epidemiology, and clinical medicine, with a particular focus on dyslipidemia, familial hypercholesterolemia, and the application of Mendelian randomization techniques to establish causal relationships in observational data. Dr. Benn actively contributes to major European clinical guidelines, including the ESC/EAS Guidelines for the management of dyslipidaemias, and her work informs evidence-based clinical practice across multiple medical specialties.

• Research has been picked up by 17 news outlets
• Blogged about by 2 sources
• Shared by 572+ X (Twitter) users
• Featured on multiple Facebook pages
• Read by numerous researchers on Mendeley

Dr. Benn maintains active collaborations with B.G. Nordestgaard and other international researchers, contributing to the European Atherosclerosis Society consensus statements and other major scientific initiatives that shape clinical practice guidelines across Europe.